NeoGenomics, Inc.

NEO ·Healthcare, Diagnostics & Research, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $12.8M $12.5M $23.4M $33.7M $4.8M $1.9M $2.6M $1.1M
Accounts Receivable $60.4M $55.5M $48.9M $20.5M $18.7M $14.0M $7.9M $5.2M
Inventory $7.5M $6.3M $5.1M $2.6M $2.3M $1.9M $1.2M $887.0K
Total Current Assets $85.9M $78.8M $82.4M $58.7M $27.5M $18.6M $13.2M $8.7M
Property, Plant & Equipment $36.5M $34.0M $34.6M $15.1M $9.7M $8.6M $6.6M $4.8M
Goodwill $147.0M $147.0M $146.4M $2.9M — — — —
Intangible Assets (Excl. Goodwill) $74.2M $77.1M $87.8M $4.2M $2.6M $2.8M $0 —
Total Assets $344.5M $337.1M $351.3M $81.1M $39.9M $30.1M $19.9M $13.7M
Liabilities
Accounts Payable $10.5M $16.8M $12.5M $6.3M $4.2M $3.6M $2.5M $1.9M
Total Current Liabilities $36.5M $38.1M $40.1M $14.6M $14.3M $17.8M $11.4M $9.2M
Long-Term Debt $91.1M $91.9M $52.3M — — — — —
Total Liabilities $139.9M $150.5M $113.2M $20.7M $18.2M $20.9M $14.1M $10.5M
Stockholders' Equity
Retained Earnings $-58.4M $-52.5M $-22.1M $-19.4M $-20.5M $-22.6M $-22.6M $-21.5M
Total Stockholders' Equity $172.0M $162.3M $208.5M $60.4M $21.7M $9.2M $5.9M $3.1M
← Newer Page 2 of 2 Older →